224 related articles for article (PubMed ID: 11092266)
1. Relationship between Propionibacterium acnes biotypes and Jumi-haidoku-to.
Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
J Dermatol; 2000 Oct; 27(10):635-8. PubMed ID: 11092266
[TBL] [Abstract][Full Text] [Related]
2. Correlation between Propionibacterium acnes biotypes, lipase activity and rash degree in acne patients.
Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
J Dermatol; 2000 Aug; 27(8):519-22. PubMed ID: 10989576
[TBL] [Abstract][Full Text] [Related]
3. Propionibacterium acnes biotypes and susceptibility to minocycline and Keigai-rengyo-to.
Higaki S; Nakamura M; Morohashi M; Yamagishi T
Int J Dermatol; 2004 Feb; 43(2):103-7. PubMed ID: 15125499
[TBL] [Abstract][Full Text] [Related]
4. Effect of lipase activities of Propionibacterium granulosum and Propionibacterium acnes.
Higaki S; Nakamura M; Kitagawa T; Morohashi M; Yamagishi T
Drugs Exp Clin Res; 2001; 27(5-6):161-4. PubMed ID: 11951573
[TBL] [Abstract][Full Text] [Related]
5. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes.
Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N
J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018
[TBL] [Abstract][Full Text] [Related]
6. Anti-lipase activity of Kampo formulations, coptidis rhizoma and its alkaloids against Propionibacterium acnes.
Higaki S; Nakamura M; Morohashi M; Hasegawa Y; Yamagishi T
J Dermatol; 1996 May; 23(5):310-4. PubMed ID: 8675819
[TBL] [Abstract][Full Text] [Related]
7. Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5.
Akamatsu H; Nishijima S; Takahashi M; Ushijima T; Asada Y
J Dermatol; 1991 May; 18(5):247-51. PubMed ID: 1834712
[TBL] [Abstract][Full Text] [Related]
8. The correlation of Kampo formulations and their ingredients on anti-bacterial activities against Propionibacterium acnes.
Higaki S; Hasegawa Y; Morohashi M; Takayoshi Y
J Dermatol; 1995 Jan; 22(1):4-9. PubMed ID: 7897023
[TBL] [Abstract][Full Text] [Related]
9. [Biotyping of Propionibacterium acnes strains isolated from patients with acne vulgaris].
Ergin C; Kaleli I; Sahin R; Ergin S; Kaçar N
Mikrobiyol Bul; 2006; 40(1-2):15-21. PubMed ID: 16775952
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Propionibacterium acnes lipase activity by the antifungal agent ketoconazole.
Unno M; Cho O; Sugita T
Microbiol Immunol; 2017 Jan; 61(1):42-44. PubMed ID: 28111792
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of Propionibacterium acnes, Staphylococcus aureus and Staphylococcus epidermidis to 10 Kampo formulations.
Higaki S; Morimatsu S; Morohashi M; Yamagishi T; Hasegawa Y
J Int Med Res; 1997; 25(6):318-24. PubMed ID: 9427165
[TBL] [Abstract][Full Text] [Related]
12. Propionibacterium acnes lipase in seborrheic dermatitis and other skin diseases and Unsei-in.
Higaki S; Morohashi M
Drugs Exp Clin Res; 2003; 29(4):157-9. PubMed ID: 15018307
[TBL] [Abstract][Full Text] [Related]
13. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
Nishijima S; Kurokawa I; Katoh N; Watanabe K
J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
[TBL] [Abstract][Full Text] [Related]
14. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
[TBL] [Abstract][Full Text] [Related]
15. Effects of Roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes.
Akamatsu H; Tomita T; Horio T
Dermatology; 2002; 204(4):277-80. PubMed ID: 12077521
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore.
Tan HH; Goh CL; Yeo MG; Tan ML
Ann Acad Med Singap; 2001 Jan; 30(1):22-5. PubMed ID: 11242619
[TBL] [Abstract][Full Text] [Related]
17. [The influence of coptidis rhizoma to lipase activity of Propionibacterium acnes].
Higaki S; Hasegawa Y; Morohashi M; Sakamoto K; Yamagishi T
Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):883-6. PubMed ID: 2232295
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
Gloor M; Wasik B; Becker A; Höffler U
Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
Kurokawa I; Nishijima S; Kawabata S
Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of two plant extracts against acne vulgaris: Initial results of microbiological tests and cell culture studies.
Kılıç S; Okullu SÖ; Kurt Ö; Sevinç H; Dündar C; Altınordu F; Türkoğlu M
J Cosmet Dermatol; 2019 Aug; 18(4):1061-1065. PubMed ID: 30414245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
